Pharmaceutical industry in Switzerland
The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people.[1] It contributes 5.7% of the gross domestic product of Switzerland and 30% of the country's exports.[1] In 2017 about 30% of Swiss exports (worth $84.8 billion) were chemical products.[2] In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion.[3]
Switzerland is home to many pharmaceutical companies, including very large groups, such as
History
- 1896: foundation of Hoffmann-La Roche.[6]
- 1933: foundation of Interpharma.
- 1950s: Janssen-Cilag.
- 1996: Ciba-Geigy merged with Sandoz, with the pharmaceutical and agrochemical divisions of both staying together to form Novartis. Other Ciba-Geigy and Sandoz businesses were sold off, or, like Ciba Specialty Chemicals, were spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz.
- 1990:
- 2000: Novartis divested its agrochemical and genetically modified crops business with the spinout of Syngenta, in partnership with AstraZeneca, which also divested its agrochemical business.
Companies
A number of pharmaceutical companies are headquartered in Switzerland:
- Hoffmann-La Roche: Basel
- Novartis: Basel
- Alcon: Geneva
- Bayer: Basel (Consumer Health Division, Hemophilia & Ophthalmology Pharma Global HQ Divisions with some Oncology)
- Lonza Group: Basel
- Abbott: Basel (Established Pharmaceuticals Division)
- Galenica: Bern
- Actelion (Johnson & Johnson): Allschwil, Basel-Land
- Janssen-Cilag (Johnson & Johnson): Zug
- Sonova: Stäfa, Zürich
- Galderma: Zug
- Ferring Pharmaceuticals: Saint-Prex, Vaud
- Octapharma: Lachen, Switzerland
- Vifor Pharma: St.Gallen
- Straumann: Basel
- Tecan: Männedorf, Zürich
- Siegfried Holding: Zofingen, Aargau
- Medela: Baar
- Acino Holding: Zurich
- Ypsomed: Burgdorf
- OM Pharma: Meyrin
- Basilea Pharmaceutica: Allschwil, Basel-Land
- Debiopharm: Lausanne
- Genedata: Basel
- Bachem: Bubendorf
- Molecular Partners: Zurich
- Senn Chemicals: Dielsdorf
- NBE-Therapeutics: Basel
- Santhera: Basel
- AC Immune: Lausanne
- Idorsia: Allschwil
- VAXIMM: Basel
- Cerbios-Pharma: Lugano
- Finox Biotech: Kirchberg, Bern
- Helsinn: Lugano
- Novimmune: Geneva
- Neovii Pharmaceuticals: Rapperswil, St Gallen
- Biognosys: Zurich
- InSphero: Schlieren
- NovaCurie: Bern
Additionally, several non-domestic pharmaceutical companies have regional headquarters in Switzerland, including:
- Accuray: Morges (International Headquarters)
- Alexion Pharmaceuticals: Zurich (EMEA Headquarters)
- Rotkreuz(European Hub)
- Baxter International: Zurich (European Headquarters)
- Beckman Coulter: Nyon (European and Emerging Markets Headquarters)
- Becton Dickinson: Eysins(European Headquarters)
- Biogen: Baar (International Headquarters)
- Bio-Rad: Basel (European Headquarters)
- Caris Life Sciences: Basel (European Headquarters)
- Bristol Myers Squibb: Boudry
- Cochlear Limited: Basel (European Headquarters)
- Edwards Lifesciences: Nyon (European Headquarters)
- Exact Sciences: Geneva (International Operations)
- Incyte: Morges (European Headquarters)
- Intuitive Surgical: Aubonne (European Headquarters)
- Neuchatel(International Headquarters)
- Medtronic: Tolochenaz (Europe & Central Asia Headquarters)
- Moderna: Basel (EMEA Headquarters)[7]
- Novo Nordisk: Zurich (International Operations)
- Seagen: Zug (European Headquarters)
- STAAR Surgical: Nidau (International Headquarters)
- SOTIO Biotech AG (European Hub)
- Takeda Pharmaceutical: Zurich (Europe & Canada Business Unit)
Finally, other companies with relevant international activities in Switzerland are:
- GlaxoSmithKline
- Merck Group
Life sciences
70% of the investments in life sciences in Europe are made in the United Kingdom, Germany, Ireland, the Netherlands, France, and Switzerland.[4][5]
In addition to pharmaceutical companies (65 companies), Switzerland is home to many companies in the fields of biotechnology (338 companies) or medical devices and technology (341 companies).
In 2013, 41 life science companies had their international headquarters (and 29 more their regional headquarters) in Switzerland.
Hubs
Basel region
According to
Lemanic region
According to
See also
- Economy of Switzerland, List of companies of Switzerland
- Science and technology in Switzerland
- European Federation of Pharmaceutical Industries and Associations, List of pharmaceutical companies
- List of largest European manufacturing companies by revenue, List of largest manufacturing companies by revenue
- Life Sciences Switzerland
- Health Valley
Notes and references
- ^ a b Stephan Vaterlaus, Stephan Suter and Barbara Fischer, "The Importance of the Pharmaceutical Industry for Switzerland", A study undertaken on behalf of Interpharma, September 2011.
- ^ Simoes, AJG; Hidalgo, CA. "OEC: The Observatory of Economic Complexity". oec.world. The Observatory of Economic Complexity. Retrieved 26 November 2019.
- ^ Simoes, AJG; Hidalgo, CA. "OEC: Which countries export Packaged Medicaments? (2017)". oec.world. The Observatory of Economic Complexity. Retrieved 26 November 2019.
- ^ a b c d e Site Selection for Life Sciences Companies, European Life Sciences Cluster 2013 Report, KPMG (page visited on 4 November 2013).
- ^ a b c d e (in French) Willy Boder, "La Suisse compétitive dans les sciences de la vie", Le Temps, Tuesday 5 November 2013, p. 15.
- ^ a b c (in French) Willy Boder, "Le grand chambardement de la pharma", Le Temps, Monday 7 July 2014, page 17.
- ^ "Moderna: about us". (in German)
- ^ a b c (in French) Dejan Nikolic, "Les sciences de la vie recrutent à Genève grâce à des ex-employés de Merck Serono", Le Temps, Tuesday 21 April 2015, page 13.
- ^ a b c (in French) Health Valley Archived 3 March 2016 at the Wayback Machine, L'Hebdo, 2010.
Bibliography
- (in French) Karl Lüönd, Principe actif: la connaissance. Passé et présent de l'industrie pharmaceutique suisse, Interpharma and éditions Neue Zürcher Zeitung, 2008.